Edwards Lifesciences Corp Q3 FY2026 results
$107.15+1.28%
Edwards Lifesciences Corp reported revenue of $1.72 billion, up 10.5% from a year earlier, net income of $308 million and diluted earnings per share of $0.53 against $0.50 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).
From its quarterly report, filed 4 Nov 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $1.72B | $1.55B | +10.5% |
| Gross profit | $1.35B | $1.21B | +11.5% |
| Gross margin | 78.5% | 77.8% | +0.7 pts |
| Operating income | $299.1M | $307.1M | −2.6% |
| Operating margin | 17.4% | 19.8% | −2.3 pts |
| Net income | $307.5M | $291.1M | +5.6% |
| Diluted EPS | $0.53 | $0.50 | +6.0% |
| Operating cash flow | $570.3M | $573.7M | −0.6% |
| Capital expenditure | $63.60M | $57.50M | +10.6% |
| Free cash flow | $506.7M | $516.2M | −1.8% |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Transcatheter Aortic Valve Replacement revenue | $1.2B | up 8.0% |
| Surgical revenue | $264.4M | up 2.5% |
| Transcatheter Mitral and Tricuspid Therapies revenue | $209.5M | up 44.3% |
| United States revenue | $1.0B | up 11.0% |
| Europe revenue | $414.6M | up 6.9% |
| Rest of World revenue | $201.3M | up 20.1% |
| Japan revenue | $92.0M | up 2.1% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sep 2026 | $1.72B | +10.5% | $0.53 |
| Q2 FY2026 | 30 Jun 2026 | $1.74B | +13.6% | $0.42 |
| Q1 FY2026 | 31 Mar 2026 | $1.65B | +16.7% | $0.66 |
| Q4 FY2025 | 31 Dec 2025 | $1.57B | +13.3% | $0.16 |
| Q3 FY2025 | 30 Sep 2025 | $1.55B | +14.7% | $0.50 |
| Q2 FY2025 | 30 Jun 2025 | $1.53B | +11.9% | $0.56 |
| Q1 FY2025 | 31 Mar 2025 | $1.41B | +6.2% | $0.61 |
| Q4 FY2024 | 31 Dec 2024 | $1.39B | +9.4% | $0.65 |
More on Edwards Lifesciences Corp: financial statements · revenue · earnings per share
EW's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.